Stefaan Van Gool

Summary

Affiliation: Katholieke Universiteit Leuven
Country: Belgium

Publications

  1. ncbi Dendritic cell therapy of high-grade gliomas
    Stefaan Van Gool
    Laboratory of Experimental Immunology, and Department of Child and Woman, Catholic University of Leuven, Leuven, Belgium
    Brain Pathol 19:694-712. 2009
  2. ncbi Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study
    Hilko Ardon
    Department of Neurosurgery, University Hospital Leuven, Catholic University of Leuven, Herestraat 49, 3000 Leuven, Belgium
    J Neurooncol 99:261-72. 2010
  3. ncbi Dendritic cell vaccination in patients with malignant gliomas: current status and future directions
    Steven De Vleeschouwer
    Department of Neurosurgery, University Hospital Gasthuisberg, Leuven, Belgium
    Neurosurgery 59:988-99; discussioin 999-1000. 2006
  4. ncbi Cytokeratin-positive meningeal peripheral PNET/Ewing's sarcoma of the cervical spinal cord: diagnostic value of genetic analysis
    Heidi Woestenborghs
    Department of Pathology, University Hospital, Catholic University of Leuven, Leuven, Belgium
    Int J Surg Pathol 13:93-7. 2005
  5. ncbi Paediatric neuroradiological aspects of Langerhans cell histiocytosis
    Philippe Demaerel
    Department of Radiology, University Hospital K U Leuven, Herestraat 49, 3000, Leuven, Belgium
    Neuroradiology 50:85-92. 2008
  6. ncbi Visual pathway glioma in children treated with chemotherapy
    Philippe Demaerel
    Department of Radiology, University Hospitals, Leuven, Belgium
    Eur J Paediatr Neurol 6:207-12. 2002

Collaborators

Detail Information

Publications6

  1. ncbi Dendritic cell therapy of high-grade gliomas
    Stefaan Van Gool
    Laboratory of Experimental Immunology, and Department of Child and Woman, Catholic University of Leuven, Leuven, Belgium
    Brain Pathol 19:694-712. 2009
    ..The strategies and results of this program are discussed in the light of the internationally available scientific literature in this fast-moving field of basic science and translational clinical research...
  2. ncbi Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study
    Hilko Ardon
    Department of Neurosurgery, University Hospital Leuven, Catholic University of Leuven, Herestraat 49, 3000 Leuven, Belgium
    J Neurooncol 99:261-72. 2010
    ..The survival data were used to power a currently running phase I/II trial...
  3. ncbi Dendritic cell vaccination in patients with malignant gliomas: current status and future directions
    Steven De Vleeschouwer
    Department of Neurosurgery, University Hospital Gasthuisberg, Leuven, Belgium
    Neurosurgery 59:988-99; discussioin 999-1000. 2006
    ..Despite recent advances in neurosurgical resection techniques, radiation therapy, and chemotherapy, malignant gliomas continue to have a dismal prognosis because relapses are unavoidable...
  4. ncbi Cytokeratin-positive meningeal peripheral PNET/Ewing's sarcoma of the cervical spinal cord: diagnostic value of genetic analysis
    Heidi Woestenborghs
    Department of Pathology, University Hospital, Catholic University of Leuven, Leuven, Belgium
    Int J Surg Pathol 13:93-7. 2005
    ..Genetic analysis plays a key role in its distinction from other small blue round cell tumors...
  5. ncbi Paediatric neuroradiological aspects of Langerhans cell histiocytosis
    Philippe Demaerel
    Department of Radiology, University Hospital K U Leuven, Herestraat 49, 3000, Leuven, Belgium
    Neuroradiology 50:85-92. 2008
    ..Neuroimaging plays an even more important role in assessing the response to treatment or possible relapse...
  6. ncbi Visual pathway glioma in children treated with chemotherapy
    Philippe Demaerel
    Department of Radiology, University Hospitals, Leuven, Belgium
    Eur J Paediatr Neurol 6:207-12. 2002
    ..MRI is an important means of monitoring the tumour response provided that a rigid imaging protocol is used to detect the early tumoral changes...